KaliVir Immunotherapeutics
Develops oncolytic immunotherapies for patients with advanced solid tumors
$14MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops oncolytic immunotherapies for patients with advanced solid tumors
Builds CXL computational memory chips and SDK for AI infrastructure in hyperscalers, telcos, and research